Interpace Biosciences Return on Investment 2010-2023 | IDXG
Current and historical return on investment (ROI) values for Interpace Biosciences (IDXG) over the last 10 years.
| Interpace Biosciences ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2023-12-31 | $0.00B | $-0.06B | -5.71% |
| 2023-09-30 | $0.00B | $-0.05B | -3.90% |
| 2023-06-30 | $0.00B | $-0.05B | -1.94% |
| 2023-03-31 | $-0.00B | $-0.05B | 4.15% |
| 2022-12-31 | $-0.00B | $-0.05B | 9.09% |
| 2022-09-30 | $-0.00B | $-0.05B | 5.10% |
| 2022-06-30 | $-0.00B | $-0.04B | 11.43% |
| 2022-03-31 | $-0.00B | $-0.03B | 23.88% |
| 2021-12-31 | $-0.01B | $-0.03B | 84.85% |
| 2021-09-30 | $-0.02B | inf% | |
| 2021-06-30 | $-0.02B | inf% | |
| 2021-03-31 | $-0.02B | 738.46% | |
| 2020-12-31 | $-0.03B | 452.17% | |
| 2020-09-30 | $-0.03B | 483.33% | |
| 2020-06-30 | $-0.03B | $-0.01B | -1200.00% |
| 2020-03-31 | $-0.03B | $-0.01B | -504.35% |
| 2019-12-31 | $-0.03B | $-0.00B | -315.15% |
| 2019-09-30 | $-0.02B | $0.03B | -235.29% |
| 2019-06-30 | $-0.02B | inf% | |
| 2019-03-31 | $-0.01B | inf% | |
| 2018-12-31 | $-0.01B | inf% | |
| 2018-09-30 | $-0.01B | inf% | |
| 2018-06-30 | $-0.01B | inf% | |
| 2018-03-31 | $-0.01B | inf% | |
| 2017-12-31 | $-0.01B | -82.76% | |
| 2017-09-30 | $0.00B | 37.21% | |
| 2017-06-30 | $0.00B | 8.51% | |
| 2017-03-31 | $0.00B | $0.03B | 13.79% |
| 2016-12-31 | $-0.01B | $0.01B | -55.81% |
| 2016-09-30 | $-0.03B | $0.00B | -269.39% |
| 2016-06-30 | $-0.03B | $0.01B | -172.15% |
| 2016-03-31 | $-0.04B | $0.01B | -147.17% |
| 2015-12-31 | $-0.04B | $0.02B | -120.59% |
| 2015-09-30 | $-0.03B | $0.03B | -83.44% |
| 2015-06-30 | $-0.03B | $0.04B | -73.62% |
| 2015-03-31 | $-0.02B | $0.04B | -57.86% |
| 2014-12-31 | $-0.02B | $0.05B | -45.03% |
| 2014-09-30 | $-0.01B | $0.03B | -19.23% |
| 2014-06-30 | $-0.00B | $0.03B | -14.29% |
| 2014-03-31 | $-0.00B | $0.04B | -13.22% |
| 2013-12-31 | $-0.00B | -6.20% | |
| 2013-09-30 | $-0.03B | $0.04B | -58.48% |
| 2013-06-30 | $-0.02B | $0.04B | -49.23% |
| 2013-03-31 | $-0.02B | $0.04B | -42.20% |
| 2012-12-31 | $-0.03B | $0.04B | -41.49% |
| 2012-09-30 | $-0.00B | $0.07B | -4.51% |
| 2012-06-30 | $-0.00B | $0.07B | -2.87% |
| 2012-03-31 | $-0.00B | $0.07B | -4.11% |
| 2011-12-31 | $-0.00B | $0.07B | -5.25% |
| 2011-09-30 | $-0.01B | $0.08B | -8.78% |
| 2011-06-30 | $-0.01B | $0.08B | -8.72% |
| 2011-03-31 | $-0.01B | $0.08B | -8.62% |
| 2010-12-31 | $-0.01B | $0.08B | -9.76% |
| 2010-09-30 | $-0.02B | $0.08B | -28.92% |
| 2010-06-30 | $-0.03B | $0.08B | -30.34% |
| 2010-03-31 | $-0.03B | $0.08B | -32.46% |
| 2009-12-31 | $-0.04B | $0.09B | -33.98% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.006B | $0.040B |
| Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.212B | 15.32 |
| Cencora (COR) | United States | $47.337B | 18.89 |
| ICON (ICLR) | Ireland | $24.074B | 23.75 |
| DiDi Global (DIDIY) | China | $22.638B | 0.00 |
| Avantor (AVTR) | United States | $16.482B | 22.71 |
| CochLear (CHEOY) | $13.356B | 0.00 | |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| Revvity (RVTY) | United States | $12.276B | 21.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.721B | 21.37 |
| Medpace Holdings (MEDP) | United States | $11.598B | 42.15 |
| Solventum (SOLV) | United States | $11.046B | 0.00 |
| Natera (NTRA) | United States | $10.540B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.851B | 51.19 |
| Bausch + Lomb (BLCO) | Canada | $5.032B | 19.35 |
| Doximity (DOCS) | United States | $4.630B | 34.47 |
| Organon (OGN) | United States | $4.566B | 4.42 |
| Sotera Health (SHC) | United States | $3.085B | 15.14 |
| Progyny (PGNY) | United States | $3.064B | 51.42 |
| Surgery Partners (SGRY) | United States | $2.965B | 27.55 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.658B | 134.60 |
| Premier (PINC) | United States | $2.491B | 9.12 |
| Teladoc Health (TDOC) | United States | $2.232B | 0.00 |
| Agilon Health (AGL) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.133B | 6.90 |
| BrightSpring Health Services (BTSG) | United States | $1.762B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.444B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.964B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.549B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.507B | 45.96 |
| MultiPlan (MPLN) | United States | $0.475B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.418B | 0.00 |
| LifeMD (LFMD) | United States | $0.412B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.356B | 57.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.286B | 3.79 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.249B | 0.00 |
| Sharecare (SHCR) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 40.00 |
| Oncology Institute (TOI) | United States | $0.091B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.015B | 0.00 | |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |